Brain hypoxia, characterized by restricted blood flow to the brain, counts for 23% of all neonatal deaths worldwide making the development of an accurate and precise patient monitoring system a top maternal-fetal health priority.
Noninvasix's novel solution utilizes optoacoustic monitoring of cerebral venous oxygenation to accurately measure the amount of oxygen a baby is receiving in real time.
Typical neonatal intensive care units save $1.1M per year, in addition to significant reductions in neonatal death and disability.
Decreased risk of malpractice suits and lower malpractice premiums.
Save $2.4M to $6.2M per year by reducing the lifetime direct medical costs associated with hypoxia-induced cerebral palsy.